Angle PLC Announces Parsortix Used to Investigate Immunotherapy Target
Leading Cancer Centre Demonstrates Use of Parsortix as a Liquid Biopsy to Investigate Key Immunotherapy Target in Lung Cancer Potential...
Day: June 21, 2019
Leading Cancer Centre Demonstrates Use of Parsortix as a Liquid Biopsy to Investigate Key Immunotherapy Target in Lung Cancer Potential...